<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0001209'>Skin ulceration</z:mp> is a cutaneous manifestation of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) and is associated with <z:mp ids='MP_0005048'>thrombosis</z:mp> of small dermal vessels </plain></SENT>
<SENT sid="1" pm="."><plain>Numerous therapeutic agents have been used but are often ineffective </plain></SENT>
<SENT sid="2" pm="."><plain>We describe the efficacy of <z:chebi fb="5" ids="28304">heparin</z:chebi> and fibrinolytic agents [urokinase and tissue plasminogen activator (tPA)] in the treatment of longstanding nonhealing cutaneous <z:mpath ids='MPATH_579'>ulcers</z:mpath> </plain></SENT>
<SENT sid="3" pm="."><plain>In one patient, <z:chebi fb="5" ids="28304">heparin</z:chebi> plus low dose tPA resulted in healing </plain></SENT>
<SENT sid="4" pm="."><plain>In another patient, treatment first with urokinase and <z:chebi fb="5" ids="28304">heparin</z:chebi>, and subsequently with tPA alone, resulted in healing </plain></SENT>
<SENT sid="5" pm="."><plain>When the <z:mpath ids='MPATH_579'>ulcer</z:mpath> recurred secondary to severe peripheral <z:hpo ids='HP_0000969'>edema</z:hpo>, tPA plus <z:chebi fb="5" ids="28304">heparin</z:chebi> led to complete resolution of the <z:mpath ids='MPATH_579'>ulcer</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>This suggests that fibrinolytic therapy and/or <z:chebi fb="5" ids="28304">heparin</z:chebi> may be useful in other recurrent thrombotic manifestations of the APS as well </plain></SENT>
<SENT sid="7" pm="."><plain>However, it must be emphatically stressed that since life threatening adverse reactions can occur secondary to <z:mp ids='MP_0001914'>hemorrhage</z:mp>, this treatment should be undertaken only after extensive evaluation and close monitoring of the coagulation status </plain></SENT>
</text></document>